Is STXS a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

300 people get STXS articles and Market Currents by email alert.

Get email alerts on STXS »

HEADLINES:

Stereotaxis' CEO Discusses Q1 2013 Results - Earnings Call Transcript
Mon, May 13
Stereotaxis Reports First Quarter 2013 Financial Results

GlobeNewswire (Mon, 4:05PM)
Stereotaxis to Highlight Enhanced Technology and Results at HRS 2013 in Denver

GlobeNewswire (May 7, 2013)
Stereotaxis Changes Date of First Quarter 2013 Conference Call to May 13, 2013

GlobeNewswire (Apr 24, 2013)
Stereotaxis to Report First Quarter 2013 Financial Results on May 2, 2013

GlobeNewswire (Apr 22, 2013)
Stereotaxis Receives Regulatory Approval of Niobe(R) Technology in Japan; Begins Commercialization Efforts

GlobeNewswire (Mar 25, 2013)
Stereotaxis' CEO Discusses Q4 2012 Results - Earnings Call Transcript
Wed, Mar 6
Stereotaxis CEO Michael Kaminski Steps Down; Board Chairman William Mills III to Serve as Interim CEO

GlobeNewswire (Mar 5, 2013)
Stereotaxis Reports 2012 Financial Results; Provides 2013 Outlook

GlobeNewswire (Mar 5, 2013)
Stereotaxis to Report Fourth Quarter and Full Year 2012 Financial Results on March 5, 2013

GlobeNewswire (Feb 26, 2013)
Stereotaxis CFO Steps Down to Pursue New Career Opportunity

GlobeNewswire (Feb 7, 2013)
Stereotaxis to Present at Oppenheimer Healthcare Conference in New York on December 13, 2012

GlobeNewswire (Dec 6, 2012)
Stereotaxis' CEO Discusses Q3 2012 Earnings Results - Earnings Call Transcript
Mon, Nov 5, 2012 • 2 Comments
Stereotaxis Reports 2012 Third Quarter Financial Results

GlobeNewswire (Nov 5, 2012)
Remaining Stereotaxis Investors Still Optimistic On Vdrive
Brian L. Wilson • Thu, Nov 1, 2012 • 1 Comment
Stereotaxis to Report Third Quarter 2012 Financial Results on November 5, 2012

GlobeNewswire (Oct 23, 2012)
Stereotaxis Elects Euan S. Thomson, Ph.D., to Board of Directors

GlobeNewswire (Oct 22, 2012)
Long Mako Surgical Alongside Insiders
InsiderInsights • Thu, Sep 13, 2012 • 14 Comments
Stereotaxis' CEO Discusses Q2 Results - Earnings Call Transcript
Mon, Aug 6, 2012
Stereotaxis Reports 2012 Second Quarter Financial Results

GlobeNewswire (Aug 6, 2012)

To learn more about Seeking Alpha Pro, click here.

Remaining Stereotaxis Investors Still Optimistic On Vdrive
Brian L. Wilson • Thu, Nov 1, 2012 • 1 Comment

Long Mako Surgical Alongside Insiders
InsiderInsights • Thu, Sep 13, 2012 • 14 Comments
Buy And Sell Ideas From Wednesday's Top Movers
GuruFundPicks • Thu, Sep 1, 2011 • 4 Comments
5 Healthcare Stocks To Consider
Timeless Wealth • Thu, Sep 1, 2011 • 4 Comments
Earnings Season Blowups, Bombs, And Disasters - By Far the Worst Earnings Season on Record
Bespoke Investment Group • Fri, Aug 19, 2011 • 2 Comments
Buy and Sell Ideas From Among Top Losers in Tuesday's Market Rebound
GuruFundPicks • Wed, Aug 10, 2011
Top Picks by Biotech and Medical Device Focused Hedge Fund DAFNA Capital Management
GuruFundPicks • Mon, May 16, 2011 • 1 Comment
Cramer's Lightning Round - Adios, Navios (3/19/10)
SA Editor Miriam Metzinger • Sun, Mar 21, 2010 • 1 Comment
Hansen Medical: A Stock to Make Any Investor's Heart Happy
Jason Kelly • Thu, Nov 12, 2009 • 9 Comments
14 Potential Short Plays
Eddy Elfenbein • Thu, Nov 27, 2008 • 6 Comments
Is Stereotaxis the Next Intuitive Surgical?
Bapcha's Stocks • Wed, Aug 20, 2008 • 12 Comments
This Week's Worst Performers of the Russell 3,000
Bespoke Investment Group • Fri, Jan 18, 2008

Stereotaxis' CEO Discusses Q1 2013 Results - Earnings Call Transcript
Mon, May 13
Stereotaxis' CEO Discusses Q4 2012 Results - Earnings Call Transcript
Wed, Mar 6
Stereotaxis' CEO Discusses Q3 2012 Earnings Results - Earnings Call Transcript
Mon, Nov 5, 2012 • 2 Comments
Stereotaxis' CEO Discusses Q2 Results - Earnings Call Transcript
Mon, Aug 6, 2012
Stereotaxis' CEO Discusses Q1 2012 Results - Earnings Call Transcript
Tue, May 8, 2012 • 1 Comment
Stereotaxis's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Mon, Mar 5, 2012 • 1 Comment
Stereotaxis' CEO Discusses Q3 2011 Results - Earnings Call Transcript
Mon, Nov 7, 2011
Stereotaxis CEO Discusses Q2 2011 Results - Earnings Call Transcript
Mon, Aug 8, 2011
Stereotaxis' CEO Discusses Q1 2011 Results - Earnings Call Transcript
Tue, May 3, 2011
Stereotaxis CEO Discusses Q4 2010 Results - Earnings Call Transcript
Mon, Feb 28, 2011 • 1 Comment
Stereotaxis CEO Discusses Q3 2010 Results - Earnings Call Transcript
Mon, Nov 1, 2010
Stereotaxis, Inc. Q2 2010 Earnings Call Transcript
Mon, Aug 2, 2010
Stereotaxis, Inc. Q1 2010 Earnings Call Transcript
Thu, May 6, 2010
Stereotaxis, Inc. Q4 2009 Earnings Call Transcript
Mon, Mar 1, 2010
Stereotaxis Inc. Q2 2009 Earnings Call Transcript
Thu, Aug 6, 2009
Stereotaxis Inc. Q1 2009 Earnings Call Transcript
Thu, May 7, 2009
Stereotaxis, Inc. Q4 2008 Earnings Call Transcript
Thu, Feb 26, 2009
Stereotaxis, Inc. Q3 2008 Earnings Call Transcript
Mon, Nov 24, 2008
Stereotaxis Inc. Q2 2008 Earnings Call Transcript
Tue, Aug 5, 2008
Stereotaxis Inc. Q1 2008 Earnings Call Transcript
Tue, May 27, 2008

Stereotaxis Reports First Quarter 2013 Financial Results

GlobeNewswire (Mon, 4:05PM)
Stereotaxis to Highlight Enhanced Technology and Results at HRS 2013 in Denver

GlobeNewswire (May 7, 2013)
Stereotaxis Changes Date of First Quarter 2013 Conference Call to May 13, 2013

GlobeNewswire (Apr 24, 2013)
Stereotaxis to Report First Quarter 2013 Financial Results on May 2, 2013

GlobeNewswire (Apr 22, 2013)
Stereotaxis Receives Regulatory Approval of Niobe(R) Technology in Japan; Begins Commercialization Efforts

GlobeNewswire (Mar 25, 2013)
Stereotaxis CEO Michael Kaminski Steps Down; Board Chairman William Mills III to Serve as Interim CEO

GlobeNewswire (Mar 5, 2013)
Stereotaxis Reports 2012 Financial Results; Provides 2013 Outlook

GlobeNewswire (Mar 5, 2013)
Stereotaxis to Report Fourth Quarter and Full Year 2012 Financial Results on March 5, 2013

GlobeNewswire (Feb 26, 2013)
Stereotaxis CFO Steps Down to Pursue New Career Opportunity

GlobeNewswire (Feb 7, 2013)
Stereotaxis to Present at Oppenheimer Healthcare Conference in New York on December 13, 2012

GlobeNewswire (Dec 6, 2012)
Stereotaxis Reports 2012 Third Quarter Financial Results

GlobeNewswire (Nov 5, 2012)
Stereotaxis to Report Third Quarter 2012 Financial Results on November 5, 2012

GlobeNewswire (Oct 23, 2012)
Stereotaxis Elects Euan S. Thomson, Ph.D., to Board of Directors

GlobeNewswire (Oct 22, 2012)
Stereotaxis Reports 2012 Second Quarter Financial Results

GlobeNewswire (Aug 6, 2012)
Stereotaxis Appoints Dr. Gery Tomassoni M.D. FHRS Chief Medical Officer

GlobeNewswire (Aug 6, 2012)
Stereotaxis to Report Second Quarter Financial Results on August 6, 2012

GlobeNewswire (Jul 26, 2012)
Stereotaxis Announces 1-for-10 Reverse Stock Split

PR Newswire (Jul 10, 2012)
Stereotaxis Appoints William C. Mills III as Chairman of Board of Directors

PR Newswire (May 30, 2012)
Stereotaxis Closes $18.5 Million Private Placement Financings

PR Newswire (May 11, 2012)
Stereotaxis Releases V-Sono™ Intracardiac Echocardiography Module for the Vdrive™ Remote Navigation System

PR Newswire (May 8, 2012)

STXS vs. ETF Alternatives

Company Description

Currently, there's no company description for STXS.

Sector: Healthcare

Industry: Medical Appliances & Equipment

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Tuesday, May 14, 12:45 PM Midday top 10 gainers: PDII +31%. UNTK +22%. ALIM +19%. SODA +15%. CHLN +15%. TEAR +14%. ESI +14%. ECTY +14%. BVSN +12%. RVLT 12%.
Midday top 10 losers: TELOZ -28%. OPXA -19%. SED -16%. STXS -14%. FMAR -13%. VELT -12%. TSRE -12%. TRMD -11%. CCCL -10%. PT -10%. Comment! [On the Move]
Monday, May 13, 4:42 PM Stereotaxis (STXS): Q1 EPS of -$0.61 misses by $0.11. Revenue of $8.41M misses by $3.59M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Monday, April 15, 12:50 PM Midday top 10 gainers: MKTAY +143%. CNIT +21%. GENE +21%. THRX +18%. MCOX +17%. SGRP +14%. S +13%. STXS +10%. ACOR +9%. LIFE +8%.
Midday top 10 losers: UNTK -48%. GSS -19%. ASM -18%. DSCO -17%. HXM -16%. XPL -16%. NGD -16%. TGD -15%. BAA -14%. PZG -14%. Comment! [On the Move]
Tuesday, March 26, 12:54 PM Midday top 10 gainers: PTEK +30%. BVX +23%. OPXA +20%. LEDS +20%. IBCP +13%. DXYN +11%. GTAT +11%. APP +11%. HGSH +9%. PGNX +9%.
Midday top 10 losers: ZIOP -62%. FUQI -17%. GMAN -16%. PGTI -14%. STSI -13%. GMXR -11%. STXS -11%. PRTS -10%. REED -10%. CSUN -8%. Comment! [On the Move]
Monday, March 25, 12:47 PM Midday top 10 gainers: STXS +56%. VBFC +14%. LEDS +13%. ERII +11%. VECO +11%. HZNP +10%. APOL +10%. SRT +10%. GSV +10%. EQU +9%.
Midday top 10 losers: PGTI -16%. IDIX -15%. JASO -13%. TSL -13%. TOPS -13%. VHC -11%. FREE -10%. JE -10%. YGE -10%. BWEN -10%. Comment! [On the Move]
Monday, March 25, 11:19 AM Stereotaxis (STXS +70%) soars after receiving regulatory approval of its Niobe remote magnetic technology for cardiac ablations in Japan earlier this morning. The approval, which is a critical milestone in securing full market entry into the country, will allow the company to begin establishing a local business infrastructure with in-country distributors, while simultaneously working on obtaining reimbursement approval for full commercial entry. Comment! [Healthcare, On the Move, Global & FX]
Tuesday, March 5, 4:43 PM More on Stereotaxis (STXS): Q4 EPS misses by a penny, but revenue comes in line with estimates. EPS were Up 45% Y/Y, with sales up 5% over the same period. Separately, the company says Michael Kaminski will step down as President and CEO, effective April 12. It names Chairman William Mills III as interim CEO and created an interim Office of the Chief Executive, with Director Dr. Euan Thomson providing support and guidance in certain areas. Shares +12.5% AH. Comment! [Earnings, On the Move, Healthcare]
Tuesday, March 5, 4:22 PM Stereotaxis (STXS): Q4 EPS of -$0.55 misses by $0.01. Revenue of $12.2M in-line. Shares +9.8% AH. (PR) Comment! [Earnings, Breaking News, Healthcare]
Friday, January 11, 12:45 PM Midday top 10 gainers: UPIP +31%. KGJI +20%. INFY +17%. DNDN +15%. REDF +14%. FLML +14%. BBY +12%. SIFY +11%. ICAD +10%. BCRX +10%.
Midday top 10 Losers: NEWL -29%. ARQL -15%. YOD -15%. PDEX -12%. BV -11%. RGLS -10%. FARO -9%. CENX -9%. MY -9%. STXS -9%. Comment! [On the Move]
Wednesday, January 2, 12:45 PM Midday top 10 gainers: ZIP +48%. BIOF +28%. STXS +25%. GIGA +21%. FORD +19%. IQNT +20%. EGLE +18%. OTT +18%. GEVO +17%. APAGF +17%.
Midday top 10 Losers: ABT -51%. SKUL -14%. DOLE -13%. TRIT -12%. ATAI -12%. HMNY -9%. CHRM -9%. NTLS -9%. VSCI -8%. MR -8%. 2 Comments [On the Move]
Friday, December 14, 2012, 12:45 PM Midday top 10 gainers: ALIM +30%. STXS +19%. QUAD +18%. RIGL +15%. CHOP +19%. OTT +16%. ZAZA +13%. ALU +12%. AXR +11%. SZYM +11%.
Midday top 10 Losers: YOD -23%. LPTN -18%. CYTX -15%. ZQK -15%. BBY -15%. USNA -11%. PAY -10%. MEIP -9%. LAS -9%. VGZ -10%. Comment!
Monday, October 22, 2012, 12:45 PM Midday top 10 gainers: STXS +56%. SVU +35%. CASC +18%. PGRX +14%. GURE +13%. CRMB +13%. LLEN +12%. CHC +12%. PRWT +11%. PETS +11%.
Top 10 Losers: OSG -63%. BSAC -62%. FSCI -29%. MSN -19%. ZN -18%. AVID -15%. HRT -6%. FDML -12%. DHRM -11%. CLWT -11%. 1 Comment [On the Move]
Monday, March 5, 2012, 4:24 PM Stereotaxis (STXS): Q4 EPS of -$0.10 beats by $0.04. Revenue of $11.6M (-20% Y/Y) beats by $1.6M. (PR) Comment! [Earnings, Healthcare]
Tuesday, August 9, 2011, 9:46 AM Shares of cardiology equipment maker Stereotaxis (STXS -57.3%) are cut in half after temporarily suspending 2011 financial guidance and announcing that its CFO would leave the company. (PR) Comment! [Healthcare, On the Move]
Tuesday, July 13, 2010, 11:10 AM Cardiology equipment maker Stereotaxis (STXS) up 21.3% after noting capital orders have more than doubled from the previous year - mainly in North America, as procedures using its equipment are steadily up. Comment!

Stockexpertpro
STXS +30% With 5 Million Shorts Trapped in the Stock this one is set to explode oversold bottom of the chart tons more room to run
6/11/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Stockexpertpro
STXS Bottom of the Chart With 5 Million Shorts Breakout Alert volume done over the avg daily volume by 2 times in the first hour of trade
6/11/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Malt Backbone
Short squeeze could be underway in STXS; Shorts are almost 20% of float and earnings later this month. But be careful, this is a dog.
2/8/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Gary Jakacky
STXS management's new motto: if you don't buy it, we will quit! Thanks for destroying a great technology, Danny Boy!
8/9/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Gary Jakacky
I really wish STXS would sell MORE medical systems and FEWER shares!
11/11/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Gary Jakacky
Since EPS last month, HNSN -14%, STXS +25%. Maybe the FDA will put a black box on HNSN statements like it does on their products?
3/9/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Gary Jakacky
STXS breaks year-long resistance at $5.25.
3/5/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Gary Jakacky
WOW! STXS up TWO WHOLE CENTS on a 100 point dow day. Will they use their CC to announce another share dilution? Put that on the TODAY show!
2/2/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

s.yazicioglu
Advice to STXS - HANSEN or STXS? which one?
1/4/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Gary Jakacky
HNSN website: The safety and effectiveness of this device...in the treatments of...atrial fibrillation, have not been established. Go STXS!
11/12/09
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

STXS Stereotaxis, Inc.

STXS

Stereotaxis, Inc.